Press release
Key Factors and Emerging Trends Shaping the Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Landscape
Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market
Projected Growth and Market Size of the Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market
The specific immunoglobulin G subclass 4 (IgG4) testing market is anticipated to experience rapid expansion, reaching a value of $2.44 billion by 2030. This represents a compound annual growth rate (CAGR) of 12.2% during the forecast period. Several factors contribute to this growth, including surging demand for precise diagnostic tools, the expansion of hospital-based testing laboratories, increased investments in laboratory automation, wider adoption of advanced immunology panels, and a stronger focus on early detection of diseases. Emerging market trends highlight the growing use of specialized immunoassays, heightened demand for autoimmune disorder diagnostics, integration of IgG4 testing into clinical practice, and continuous advancements in immunology laboratory automation aimed at improving diagnostic accuracy.
Download a free report of the specific immunoglobulin g subclass 4 (igg4) testing market report:
https://www.thebusinessresearchcompany.com/report/global-specific-immunoglobulin-g-subclass-4-igg4-testing-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Corporations Driving the Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market
The market features several prominent organizations actively engaged in the specific IgG4 testing sector, including F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Revvity, Randox Laboratories Ltd, NeoGenomics Laboratories Inc., ARUP Laboratories, Dr Lal PathLabs Limited, Metropolis Healthcare Ltd, ProSci Incorporated, Leinco Technologies Incorporated, MyBioSource Inc., Boster Biological Technology, PROTIA Inc., and Creative Diagnostics LLC.
Significant Strategic Moves in the Market
In December 2023, Danaher Corporation, a US-based provider specializing in life sciences, diagnostics, and biotechnology solutions, completed its acquisition of Abcam plc for $5.7 billion. This strategic move allows Danaher to access Abcam's wide range of antibodies, recombinant proteins, assay kits, and immunoassay reagents, strengthening its immunodiagnostic portfolio, particularly in workflows involving specific IgG4 testing. Abcam, headquartered in the UK, is renowned for its expertise in antibody development and standardized ELISA platforms, including high-quality research-grade IgG4-specific tools widely used in immunology and biomarker studies. This acquisition boosts Danaher's global research infrastructure, operational scale, and customer outreach capabilities.
View the full specific immunoglobulin g subclass 4 (igg4) testing market report:
https://www.thebusinessresearchcompany.com/report/global-specific-immunoglobulin-g-subclass-4-igg4-testing-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Innovations and Emerging Trends Enhancing the IgG4 Testing Market
Companies in the specific IgG4 testing market are increasingly focusing on innovation by integrating high-sensitivity immunoassay technologies into their platforms. These advanced immunoassays utilize optimized antibodies, improved signal detection chemistries, and refined assay procedures to measure extremely low analyte levels with greater precision. This translates into enhanced detection limits, higher specificity, and consistent reproducibility, all of which contribute to better diagnostic reliability.
An example of innovation in this field occurred in September 2025 when Alta DiagnoTech, a US-based developer of in vitro diagnostic immunoassay solutions, introduced its ELISA Kits for IVD Immunology Testing. This product line employs high-sensitivity immunoassay technology designed for accurate biomarker quantification across various immunological applications. The kits are noted for their improved assay sensitivity, manufacturing stability, and versatility in immunology workflow integration, leading to increased confidence in diagnostic outcomes.
Market Segmentation Overview of the Specific Immunoglobulin G Subclass 4 (IgG4) Testing Industry
This report categorizes the specific IgG4 testing market into several key segments:
1) Product Type:
- Reagents and Kits
- Instruments
- Services
2) Application Areas:
- Allergy Diagnosis
- Autoimmune Disease Diagnosis
- Research
- Other Applications
3) End-User Categories:
- Hospitals and Clinics
- Diagnostic Laboratories
- Research Institutes
- Other End-Users
Further breakdown includes:
- Within Reagents and Kits: Purification Reagents, Detection Reagents, Assay Kits, Calibrators, Controls
- Within Instruments: Automated Analyzers, Enzyme Linked Immunoassay Readers, Microplate Washers, Sample Preparation Systems, Laboratory Automation Platforms
- Within Services: Testing Services, Validation Services, Quality Assurance Services, Custom Assay Development Services, Technical Support Services
These segments collectively provide a comprehensive view of the IgG4 testing market's structure and highlight areas of focus for manufacturers, healthcare providers, and researchers alike.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Factors and Emerging Trends Shaping the Specific Immunoglobulin G Subclass 4 (IgG4) Testing Market Landscape here
News-ID: 4487330 • Views: …
More Releases from The Business Research Company
Leading Companies Reinforcing Their Presence in the Stem Cell Therapy for Multip …
The field of stem cell therapy for multiple sclerosis (MS) is rapidly evolving, showing promising growth and innovation. Advances in medical research and increasing demand for effective treatments are setting the stage for this market's expansion over the coming years. Let's explore the current market size, key players, emerging trends, and important segments shaping this specialized healthcare area.
Expected Market Growth and Size of Stem Cell Therapy for Multiple Sclerosis …
Emerging Growth Patterns Driving Rapid Expansion in the Stem Cell Cryopreservati …
The stem cell cryopreservation market is poised for remarkable expansion as advancements in regenerative medicine and biobanking drive demand. Increasingly sophisticated storage solutions and automation are shaping the future of how stem cells are preserved for therapeutic and research purposes. The following sections explore the market's size, key players, emerging trends, and major segments to provide a comprehensive view of this rapidly evolving field.
Projected Market Size and Growth Prospects of…
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the S …
The status epilepticus market is on track for notable expansion as advancements in treatment options and monitoring technologies continue to evolve. With increasing innovation and a growing focus on personalized care, this sector is poised for sustained growth through the end of the decade. Below is an in-depth look at the market's size, key players, emerging trends, and major segments driving its development.
Projected Growth and Size of the Status Epilepticus…
Emerging Sub-Segments Transforming the Spinal Stenosis Treatment Market Landscap …
The spinal stenosis treatment market is poised for steady advancement over the coming years as healthcare providers seek more effective and personalized approaches to managing this condition. Innovations in pain management, rehabilitation, and minimally invasive techniques are driving positive changes that promise improved patient outcomes and broadened therapeutic options. Let's explore the market's size, key players, emerging trends, and segment details to get a clearer picture of its future direction.
Projected…
More Releases for IgG4
IgG4-Related Disease Market Growing at a CAGR of around 7.4%
IgG4-Related Disease Market
The IgG4-Related Disease (IgG4-RD) market was valued at ~USD 650 million in 2024 and is projected to reach ~USD 1.32 billion by 2034, growing at a CAGR of around 7.4%. Growth is driven by rising diagnosis of autoimmune fibro-inflammatory disorders, increasing specialist awareness, and expanding use of targeted biologics.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71321
Key Market Drivers
• Improved detection through serum IgG4 testing, biopsy, and imaging.
• Rising…
IgG4 - Related diseases Market: Epidemiology, Therapies, Companies, DelveInsight …
The market for IgG4-related diseases is anticipated to grow in the coming years, driven by emerging therapies such as Obexelimab (XmAb5871) and others.
DelveInsight has released a comprehensive report titled "IgG4-Related Diseases - Market Insights, Epidemiology, and Market Forecast 2034", providing an in-depth analysis of IgG4-related diseases, including historical and projected epidemiology, as well as market trends across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and…
IgG4-Related Disease Market Set for 34.6% CAGR Growth: Market Drivers and Opport …
DelveInsight's latest market analysis reveals an unprecedented growth trajectory for IgG4-Related Disease therapeutics, featuring breakthrough approvals from Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi targeting multi-organ autoimmune condition.
Key Findings
*
Market size projection: As per DelveInsight's analysis, the total market size of IgG4-Related Disease in the 7MM is expected to reach approximately USD 182 million in 2025, projected to grow at a remarkable CAGR of 34.6% by 2034.
*
Market Drivers: Key market…
IgG4-Related Disease Market to Quadruple, Hitting USD 4 Billion by 2034
IgG4-related disease (IgG4-RD) is a rare, chronic, immune-mediated condition characterized by fibroinflammatory lesions that can affect multiple organs, including the pancreas, salivary glands, kidneys, lungs, and lymph nodes. Often misdiagnosed as cancer or other autoimmune diseases, IgG4-RD has emerged as a significant area of focus in rare disease and immunology research.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71321
Traditionally managed with corticosteroids and immunosuppressants, treatment is evolving with B-cell…
IgG4 - Related diseases Market: Epidemiology, Therapies, Companies, DelveInsight …
IgG4 - Related diseases emerging therapies, such as Obexelimab (XmAb5871), and others, are expected to boost the IgG4 - Related diseases Market in the upcoming years.
DelveInsight has launched a new report on "IgG4 - Related diseases - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the IgG4 - Related diseases, historical and forecasted epidemiology as well as the IgG4 - Related diseases market trends in the…
IgG4-related disease Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trial …
(Albany, USA) DelveInsight's "IgG4-related disease Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of IgG4-related disease, historical and forecasted epidemiology as well as the IgG4-related disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The IgG4-related disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted IgG4-related disease…
